Habata S - Search Results

1

BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression.

Habata S, Iwasaki M, Sugio A, Suzuki M, Tamate M, Satohisa S, Tanaka R, Saito T. Habata S, et al. Oncol Rep. 2015 May;33(5):2613-21. doi: 10.3892/or.2015.3831. Epub 2015 Mar 4. Oncol Rep. 2015. PMID: 25738313

2

BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer.

Sugio A, Iwasaki M, Habata S, Mariya T, Suzuki M, Osogami H, Tamate M, Tanaka R, Saito T. Sugio A, et al. Among authors: habata s. Gynecol Oncol. 2014 Sep;134(3):615-23. doi: 10.1016/j.ygyno.2014.06.024. Epub 2014 Jun 30. Gynecol Oncol. 2014. PMID: 24992675

3

Preservation of fertility and subsequent childbirth after methotrexate treatment of placenta percreta: a case report.

Tamate M, Matsuura M, Habata S, Akashi Y, Tanaka R, Ishioka S, Endo T, Saito T. Tamate M, et al. Among authors: habata s. J Med Case Rep. 2015 Oct 19;9:232. doi: 10.1186/s13256-015-0716-3. J Med Case Rep. 2015. PMID: 26480940 Free PMC article.

4

BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer.

Habata S, Iwasaki M, Sugio A, Suzuki M, Tamate M, Satohisa S, Tanaka R, Saito T. Habata S, et al. Int J Oncol. 2016 Jul;49(1):402-10. doi: 10.3892/ijo.2016.3494. Epub 2016 Apr 21. Int J Oncol. 2016. PMID: 27120977

5

ERα increases endometrial cancer cell resistance to cisplatin via upregulation of BAG3.

Abe S, Iwasaki M, Habata S, Mariya T, Tamate M, Matsuura M, Satohisa S, Saito T. Abe S, et al. Among authors: habata s. Oncol Lett. 2021 Jan;21(1):20. doi: 10.3892/ol.2020.12281. Epub 2020 Nov 9. Oncol Lett. 2021. PMID: 33240426 Free PMC article.

6

Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma.

Akimoto T, Takasawa A, Takasawa K, Aoyama T, Matsuura M, Tamate M, Iwasaki M, Habata S, Murakami T, Osanai M, Saito T. Akimoto T, et al. Among authors: habata s. Med Mol Morphol. 2022 Dec;55(4):275-282. doi: 10.1007/s00795-022-00329-6. Epub 2022 Jul 25. Med Mol Morphol. 2022. PMID: 35876908

7

CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas.

Moridi I, Mamillapalli R, Kodaman PH, Habata S, Dang T, Taylor HS. Moridi I, et al. Among authors: habata s. Reprod Sci. 2020 Sep;27(9):1724-1730. doi: 10.1007/s43032-020-00166-x. Epub 2020 Feb 4. Reprod Sci. 2020. PMID: 32020550

8

Donor Mesenchymal Stem Cells Program Bone Marrow, Altering Macrophages, and Suppressing Endometriosis in Mice.

Habata S, Mamillapalli R, Ucar A, Taylor HS. Habata S, et al. Stem Cells Int. 2023 Jul 28;2023:1598127. doi: 10.1155/2023/1598127. eCollection 2023. Stem Cells Int. 2023. PMID: 37545483 Free PMC article.

9

CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking.

Pluchino N, Mamillapalli R, Shaikh S, Habata S, Tal A, Gaye M, Taylor HS. Pluchino N, et al. Among authors: habata s. J Cell Mol Med. 2020 Feb;24(4):2464-2474. doi: 10.1111/jcmm.14933. Epub 2020 Jan 6. J Cell Mol Med. 2020. PMID: 31904910 Free PMC article.

10

Endometriosis Cell Proliferation Induced by Bone Marrow Mesenchymal Stem Cells.

Chen P, Mamillapalli R, Habata S, Taylor HS. Chen P, et al. Among authors: habata s. Reprod Sci. 2021 Feb;28(2):426-434. doi: 10.1007/s43032-020-00294-4. Epub 2020 Aug 18. Reprod Sci. 2021. PMID: 32812213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters